Financhill
Back

Elite Pharmaceuticals, Inc. 10K Form

Sell
15

ELTP
Elite Pharmaceuticals, Inc.

Last Price:
$0.38
Seasonality Move:
30.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive ELTP News And Ratings

See the #1 stock for the next 7 days that we like better than ELTP

ELTP Financial Statistics

Sales & Book Value

Annual Sales: $84M
Cash Flow: $-5.5M
Price / Cash Flow: 25.07
Annual Sales: $0.07
Price / Book: 5.25

Profitability

EPS (TTM): 0.02170
Net Income (TTM): $43.4M
Gross Margin: $38.4M
Return on Equity: 77.64%
Return on Assets: 40.04%

Elite Pharmaceuticals, Inc. Earnings Forecast

Key Elite Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 29 years for ELTP is 45.69%.
  • The Selling, General & Administrative Expenses for ELTP have been equal to 10.71% of Gross Profit Margin.
  • The Research & Development expenses have been 9.48% of Revenue.
  • The Net Earning history of ELTP is -5.13% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 11 years.

Elite Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ELTP
Website: elitepharma.com

Debt

Debt-to-Equity Ratio: 0.08
Current Ratio: 7.34
Quick Ratio: 5.38

Price-to-Earnings

Trailing P/E Ratio: 36.6
Forward P/E Ratio: 0

ELTP Technical Analysis vs Fundamental Analysis

Sell
15
Elite Pharmaceuticals, Inc. (ELTP) is a Sell

Is Elite Pharmaceuticals, Inc. a Buy or a Sell?